Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Canaccord Genuity lowers target price on Thor Explorations

(Sharecast News) - Analysts at Canaccord Genuity lowered their target price on mineral exploration company Thor Explorations from 35.0p to 30.0p on Monday following the group's fourth-quarter results. Thor Exploration's latest set of quarterly figures showed gold production in line with prior expectations at 21,800 ounces, bringing full-year production to roughly 85,000 ounces, meeting the company's guidance. Additionally, head grades were higher than the prior quarter at 2.77 grams per tonne despite lower mined ore grades.

Berenberg said 2023 was expected to be "a difficult year" in the mine plan, but it also noted that production guidance of 95,000-100,000 ounces for 2024 had come in lower than previous estimates of approximately 105,000 ounces and all in sustaining cost guidance was higher than previous expectations of $880.0 per ounce at $1,150.0-$1,350 per ounce, prompting the adjustments in its earnings estimates and valuation.

"We note that with this year's more realistic figures, the company still trades on an FY24E EV/EBITDA of ~1x, and with a significantly lower debt repayment burden than that seen in 2022 (we expect ~US$18m in repayments this year)," said Berenberg, which reiterated its 'buy' rating on the stock.

"This sets the stage for a year where the company not only reaches a net cash position (CGe: 1H24), but we expect a significant share of the current market cap to be held in net cash by year-end (~40-50%)."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.
McCarthy out, Adshead in as Ultimate Products chair
(Sharecast News) - Ultimate Products, the parent of homeware brands including Salter and Beldray, announced a change in its leadership on Monday, with James 'Jim' McCarthy deciding to step down as non-executive chair from 31 July.
Supermarket Income REIT buys portfolio of Carrefour supermarkets for €75.3m
(Sharecast News) - Supermarket Income REIT said on Monday that it has bought a portfolio of Carrefour supermarkets in France through a sale and leaseback transaction for €75.3m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.